Rijksinstituut voor Volksgezondheid en Milieu Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy | RIVM Jaar: 2024 Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy | RIVM Bron: rivm.nl Download dossier (ZIP) · JSON